title: Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
abstract: Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhibitor. This case report raises awareness among physicians worldwide of this often unknown association, as life-threatening cardiac and neuromuscular complications can arise with unrecognized hypocalcemia and hypomagnesemia with proton pump inhibitors.
authors.affiliation: Department of Endocrinology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India.
authors.forename: Krishnan
authors.initials: K
authors.lastname: Swaminathan
mesh_terms: D000328:Adult; D064098:Esomeprazole / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced* / Q000150:complications*; D007011:Hypoparathyroidism / Q000139:chemically induced* / Q000150:complications*; D008275:Magnesium Deficiency / Q000139:chemically induced / Q000150:complications / Q000151:congenital*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*
chemical_list: D054328:Proton Pump Inhibitors; D064098:Esomeprazole
keywords: Hypocalcemia; hypoparathyroidism; proton pump inhibitors; tetany